REC · INTERNAL

SALTWATER PRESENTS

WATCH APERFORMANCE

One night only · Tue 28 Jul 2026 Tom McLeod, category lead Doors 15 min · Q&A 10 Live music · theater · immersive · residencies · festivals · comedy · venues · live-event IP

The biggest map on the wall, and the narrowest door in. Four structural gaps the majors can't serve. We hold the keys to all four.

Scroll, or press J/K to walk the cues

CUE 01LX: house to half, single spotTHE ANSWER, UP FRONT

The category clears the bar.
The bridge is conditional.

The majors — Live Nation, AEG, CTS Eventim, KKR/CVC-backed Superstruct — already consolidated the obvious assets at ~11x EBITDA. Our playable market is not "live entertainment." It is four structural gaps the majors can't or won't serve: estate live-IP carve-outs that aren't for sale as companies (the JGE pattern), promoter and residency credit below institutional size (the iKon pattern), founder-run festivals pre-consolidation (the ASF pattern), and demand-gen-advantaged formats we see early through Fever.

The mechanism, named

3–5x in, 9–11x out

Roll-up multiple arbitrage on fragmented promoter and festival EBITDA, amplified by IP-attach economics, funded ~80% by outside capital that Stage 1 proof points unlock. Operating leverage alone cannot do it: promoter margins run 3–7%.

The honest cap

$150–250M

If the Concentrate test fails — assets share a theme but no operating engine — this is a very good SPV franchise, not a platform. That finding goes to the room, not under the rug.

Category score

~3.9 / 5

Strong category, contingent bridge. Fund Stage 1 fully. Make Stage 2 ambition explicitly conditional on proof points 1–3 and the quarterly entry-multiple monitor.

CUE 02LX: sodium amber washSECTION A1 · MARKET MAP + TAM / SAM, SOURCED

Act I · The room we're playing

Size the room before you book it

TAM — with the honest caveats
LayerSizeEvidence & caveat
Global live music~$38–55B ('25–'26)
6–9% CAGR
CMI: $38.58B (2025) growing 8.78% to $62.6B by 2034. Mordor: $54.5B (2026) to $72.4B by 2031. Estimates diverge ~40% on definition — ticketing and sponsorship inclusion. Working band: $40–50B.
Live Nation (consolidated-core proxy)>$25B rev FY2025Revenue +9% YoY. Concerts $20.9B (83%, +10%), ticketing $3.1B (12%), sponsorship $1.3B (5%). 159M fans (+5%). AOI $2.4B. LN alone is more than half the global market — the defining structural fact of the category.
Broadway (US commercial theater proxy)~$1.9B / season2024–25: record $1.89B, 14.7M attendance. 2025–26: $1.91B, a record again — but attendance fell ~0.5% and price ($131 avg) did the work. Read: price-led records masking flat volume. Hit-driven market.
Residencies / immersive venuesSphere = the datapointSphere Ent. FY2025 revenue $1.22B (+8%). The Vegas venue grossed $379M on 1.7M tickets in 2025 — highest-grossing arena on earth per Pollstar. Wizard of Oz: 2.2M tickets, ~$290M, ~$132/ticket since Aug '25.
Comedy (fastest-growing sub-segment)Top 10 ≈ $400M grossTop 10 comedy acts grossed $396.7M in 2024, +52% YoY (Billboard). 2025 softened on all-in pricing and macro; executives forecast a strong 2026. Low production cost, high margin, extreme talent-dependency.
"Immersive entertainment" headline TAMsUnusableMordor claims $147B (2026) but folds in theme parks, VR, escape rooms. The investable immersive-theater slice is likely low single-digit $B. A defensible bottoms-up number was not attainable in a week — flagged per house rules. We do not cite this as our market.

SAM — what we can actually transact against

Estate live-IP carve-outs

$0.5–1B/yr

Licensable rights value entering play. No market report exists; deal-by-deal. Estimate, ours.

Sub-radar festival M&A

2–5x entry

Superstruct's own bolt-ons: 70% of Snowbombing for £3.95M, 70% of Cross The Tracks for £1.7M, 60% of a Barcelona EDM promoter for £3.48M. The platform sold to KKR at €1.3B — 10.8x €120M EBITDA.

Promoter / residency finance

$300–500M/yr

iKon alone seeks $50M. Sphere production runs $5–12M/day with $7–10M A-list guarantees. Estimate from iKon + the EverWonder $60M vehicle.

That 2–5x-in, 10x-out spread is the single most important number in this presentation. Everything in Act III hangs off it.

Sources: Custom Market Insights 5/30/26 · Mordor Intelligence 2026 · Billboard 2/20/26 · Music Business Worldwide 2/19/26 · LN 10-K via StockTitan · Broadway League 5/25 · Playbill 5/27/26 · CRE Daily & Pollstar 7/26 · Accio/Billboard 5/26 · Pollstar exec survey 1/16/26 · MBW 3/5/25 · NKP M&A / Reuters 6/24. SAM figures are our estimates, labeled as such.

CUE 03LX: amber, full stageSECTION A1 · THE ENTITIES THAT MATTER, SEGMENTED

The players, by layer

Value chain top to bottom. Amber outline marks our positions and pipeline. Struck-through means excluded by standing verdict. Hover any name for the one-line read.

IP / Licensingbreaks the value-chain cap · where $500M is won
Cirque du Soleil Punchdrunk JGE · Garcia estate Grace · Wakeley Gonda anime IP Ampersand Pophouse Primary Wave · ABG
Runs & Operateswhere the FCF is
Live Nation AEG Presents Superstruct / CVC Insomniac iKon Presents ASF Silencio Danny Wimmer Presents UNTOLD Sphere / MSG Broadway operators
Designs & Buildscapped near ~20% of client budget
Agencies (MATTE, NVE, Kamp Grizzly…) Moment Factory TAIT · disguise
Ticketing / Demand-genFever conflict zone
Fever TodayTix / MARI Ticketmaster DICE Posh
Saltwater position or live pipeline Excluded by standing verdict Context, comp, or counterparty

Explicit exclusions: pure venue propcos (opco/propco stay separate), generalist ticketing, agencies below Moment Factory scale, and the undifferentiated middle tier — regional 2,000-cap venues with no IP. The category's graveyard. Professional-networking column eliminated previously; not revisited.

CUE 04LX: amber, movers sweepSECTION A2 · REPEATABLE SOURCING MOTION + MANUFACTURING DEALS

Where the deals actually come from

Motion 1 · Fever's producer graph

Highest signal. Fever holds equity in top producers (Moment Factory went $27M to $150M through Fever) and sees demand data on every format before the market does. Motion: quarterly review of Fever's top-20 producer partners; approach the two or three with owned IP and no institutional capital.

Motion 2 · Estate referrals

Proprietary. JGE and Grace make us the known buyer for live rights nobody knows how to structure. Estates talk through the same five lawyers. Motion: map the ~10 estate attorneys and business managers behind Garcia/Dylan/Ali-class estates; standing offer architecture — license plus advisory plus capital option, never acquisition.

Motion 3 · Vegas residency network

Structurally underserved. Promoters needing show-level capital are too small for institutional credit and too risky for banks. Motion: iKon as the template term sheet; make the $3–10M credit-with-kicker facility known in the Sphere and Vegas production community.

Motion 4 · Festival succession sellers

Superstruct's leftovers. Founder-run 15–30K festivals facing burnout and cost inflation, ideologically anti-KKR — the 230+ artist open letter, Brian Eno among the signatures, is our cold-call script. Motion: ASF as the reference deal; work the ILMC and European festival-association circuit.

Manufacturing deals that aren't for sale

Carve-out

Estate live rights, JGE model: a 15–25 year license vehicle. The estate keeps the catalog. Nothing was for sale until we papered it.

Incubation

Ampersand: capital plus strategy at holdco level before there's a company to buy. Discipline applied: one sub-$50 anchor-ticket product before anything premium.

Operator recruitment

The Garnet Street analog. Don't buy venues or festivals — recruit the best residency and festival operators and back them into assets we structure. Find the best franchisee of live performance.

Reluctant sellers

Structured equity ladder: 10–20% plus milestones plus call options priced today. Superstruct proved sellers accept 60–70% with earnouts. We offer the friendlier minority version, with a path.

CUE 05LX: tight amber specialsSECTION A3 · SALTWATER'S SPECIFIC RIGHT TO WIN

Why us. Specifically.

1 · Fever information asymmetry

Demand-side data plus a producer equity graph nobody else at our size sees. Built-in distribution exit for anything we incubate — the Bruce Lee hand-off proved the lane runs both ways.

2 · Estate-structuring record

JGE (15-year Garcia rights) plus Grace (first to align all four Beatles parties). Two-deal proof we can paper trust-based rights deals institutions can't. Primary Wave buys catalogs; we structure live rights. Different product, less competition.

3 · Credit-with-kicker template

The iKon term sheet plus E1's discipline — cash-flow component or real-estate backing on every deal. An underwriting playbook VCs don't have and banks won't touch.

4 · A cultural LP base

Our LPs — operators, next-gen family offices — are the counterparty estates and founders want. Anti-KKR festival sentiment plus anti-LN artist sentiment makes "not institutional PE" a priced advantage, not a vibe.

5 · Speed at sub-institutional size

$2–10M checks, 30-day papering, in a category where the majors' minimum deal size starts above our maximum.

What we do not have

Operating capability to run venues or festivals — we never pretend otherwise. Music-bank leverage relationships. Any edge in generalist touring.

CUE 06LX: amber holdSECTION A4 · QUALIFIED OPPS / QUARTER · CONVERSION TO TERM SHEET AND CLOSE

Pipeline math that admits its own risk

Qualified / quarter

12–16

Fever graph 2–3 · estate referrals 1–2 · promoter finance 2–3 · festival succession 1–2 · comedy & immersive 2–3 · LP-network inbound 1–2. Consistent with actuals: eight live names accumulated over ~two quarters before expansion.

Conversion

20% → 50%

Qualified to term sheet ~20% — taste bar, IP test and Fever screen kill more names as volume rises. Term sheet to close ~50%. Net: 1–1.5 closes per quarter.

18-month output

6–9 closes

At $2.5–4M average. Matches $25M: the $18M slug takes 3–4 FCF deals, the $7M sleeve takes 2–3 IP and taste positions including one or two $250K checks.

Honesty check: estate deals run six-to-twelve-month cycles with binary family risk. See Esme Grace. The expanded universe's real gain is 2x coverage on every sleeve, so Stage 1 no longer depends on any single family or founder saying yes.

CUE 07LX: crossfade to tide tealSECTION B1 · FIRST-CHECK PROFILE — WHICH SUB-SEGMENTS THROW OFF CASH

Act II · First set — months 0–18, the $25M

Where distributable cash actually lives

The test for the $18M slug: throws off cash an LP can receive within 18 months. Everything else is a different bucket or a different category.

Sub-segment audit
Sub-segmentDistributable?Mechanism & evidenceVerdict for the $18M
Independent promoters (show-level)Yes — best shapeiKon: 54 shows, $21.9M rev, ~$7M net (2025). Waterfall returns capital + preferred per project. Debt collateralized against pre-sales and guarantees (Mayweather $15M / Pacquiao $12M; the EverWonder/Netflix $60M vehicle validates at scale).CORE. Credit + kicker. Self-liquidating. Best downside shape in the category.
Residency / production financeYes — per-projectSphere production $5–12M/day; $7–10M A-list guarantees; minimum 10 dates. The venue side works ($379M gross 2025, top arena globally). The financeable gap is the production and promoter layer.CORE. Same instrument. Underwrite the guarantee, not the artist.
Profitable festivals (P&L level)Yes — annualSuperstruct bolt-on evidence: 60–70% founder-festival stakes at £1.7–4M, roughly 2–5x EBITDA implied. A 25–30K festival at €1–2M EBITDA distributes annually.CORE at the right price. ASF template: advisory + fixed-price option beats buying today.
Venue opcos with IPConditionalSilencio: €7M rev, €2M EBITDA on 6,000 sq ft. Real FCF — but the €10M raise consumes it for expansion. You're buying growth, not distributions.Only with a distribution covenant, or via SPV pricing the expansion risk. Unfocused-scope concern stands.
Commercial theater (Broadway / West End)NoRecord $1.91B season with attendance down ~0.5% and price doing the work. Rising costs, ever-shorter windows for shows to find footing. Hit-driven, binary per-show outcomes.Excluded from the slug. Theater exposure lives in the $7M sleeve via Ampersand and Pasek IP only.
ComedyNo at talent levelTop-10 comedy grossed $396.7M in 2024, +52% — and talent captures nearly all of it. Fails the talent-dependency screen. Format and room IP is the only investable surface, and it's early.Watch list, not Stage 1 capital.
Touring at scaleNo for usLN concerts run a 3.3% AOI margin on $20.9B. A scale-and-flow business we can't play.Context only.
CUE 08LX: teal, warm specials on the deskSECTION B1 · THE ~$18M FCF SLUG — SIZE, CONTROL, DEBT VS EQUITY, GOVERNANCE

The $18M is anchor capital,
not direct positions

Every dollar anchors a $10M+ SPV. Gating rule holds: no outside capital, no deal. One tension for the room, stated plainly: Fever fits neither bucket cleanly — mid-stage growth equity, not distributing FCF. Recommendation: it sits inside the $18M as the designated platform exception. That's a decision, not a footnote.

Instrument 1 — the product we manufacture

Credit line with equity kicker (iKon template). Per-project draw-down. Waterfall: investor whole + preferred, then split. Kicker: 5–15% warrant or equity. Self-liquidating in 12–24 months.

Instrument 2

Structured minority, 10–20%, with a papered annual distribution policy, a milestone ladder to 25–35% with calls priced today (ASF's fixed $8M is the model), information rights, negative controls.

Never

Control acquisitions — we can't operate. Venue propco. Unsecured show finance without guarantees or pre-sales collateral.

Working allocation — for debate, not precision
Position$BucketStructureStatus
Fever SPV anchor$3–5MMid-stage — flagged platform exceptionSecondary at 10–15% discount; fees to ManCoClosing Aug/Sep 2026
iKon-type credit facility #1$4–5M → $10–15M SPVCash-flowingCredit + kicker, per-project drawsTerm sheet ready; structure is the diligence
Promoter / residency facility #2 (new name via Motion 3)$3–4M anchorCash-flowingSame templateManufacture, months 6–12
Festival positions (ASF option reserve + one succession seller)$2–3MCash-flowingASF fixed-$8M option (24-mo) + one 15–25% structured minorityASF live; second name from the ILMC circuit
Silencio (conditional)$2–3MCash-flowing, if covenant + focus resolvedSPV with French family co-investorsDiligence. Kill if scope stays clubs + hotels + festivals
Unallocated reserve$1–2MFollow-on / broken-deal buffer

Governance minimums, every deal: monthly financials with show-level P&L. Distribution policy in the docs, not in trust. Negative controls on M&A, related-party transactions, budget variance over 15%. Key-man and talent-dependency provisions — iKon's promoter relationships, Silencio's booking network post-Lynch. Board seat or observer on equity; covenant package on credit.

CUE 09LX: teal, single follow-spotSECTION B1 · THE ~$7M ASYMMETRIC SLEEVE

The $7M sleeve is already 70% spoken for

The job is closing and structuring, not sourcing. Every sleeve position passes the three-question IP test at underwriting, with Q3 — a third party pays to attach — as the explicit bull-case driver. That's what makes these asymmetric rather than merely illiquid.

IP SPV anchor · $2.5–3M

Into the $20M+ vehicle. JGE at 12.5% direct + transfer rights + second board seat — hold the line from the bridge-loan pass. Grace re-engagement after the film wraps mid-August. Positioning per house view: not a financial product. Story, access, perks papered. Bear 2–3x via cash flows; bull 6–10x. Don't call it a fund.

Ampersand incubation · $2–2.5M

Holdco level — wherever Agnes gets paid, that's where our money sits. Condition precedent: a prioritized slate. One sub-$50 anchor-ticket product first, not nine ideas. The engaged-bet minimum applies: below $2M we don't matter to her.

Taste checks · 2 × $250K

The Donald Glover filter. Candidates: the Benj Pasek vehicle; one comedy format where the room or show is the asset and talent doesn't need to be present, or undervalues its own IP. TYGER stays watch-only.

Reserve · ~$1M

For one Fever-graph surprise: a producer with owned IP and no institutional capital, surfaced by Motion 1.

CUE 10LX: teal, buildSECTION B1 · THE PROOF POINTS THAT EARN MORE CAPITAL

Three proofs buy the next act

Proof 1 · month 12–15

One full credit cycle

Capital drawn, shows executed, waterfall pays. Documented net IRR of 15–20%+ with zero principal impairment. Proves promoter finance is a repeatable manufactured product — unlocks facilities #2 and #3 and a dedicated credit sleeve at Concentrate.

Proof 2 · by month 18

IP passes Q3 in the wild

One third-party licensing or attachment deal — a brand, a venue, or a Fever-distributed format paying to attach to Garcia or Grace IP — or a first cash distribution. The single highest-leverage proof for the $500M story.

Proof 3 · rolling

ManCo covers the category

Fever SPV + IP SPV closed at $30M+ combined third-party AUM with fee income at or above the category's fully loaded cost. Proves the origination flywheel: we're paid to build the platform.

Explicitly not a proof point: paper markups on the sleeve. Trajectory is not marks.

CUE 11LX: teal holdSECTION B1 · TEAM / INFRA COSTS AGAINST THE MANCO

The category pays its own crew, or it doesn't tour

Cost, 18 months

$700–950K

Tom (lead) + ~0.3 FTE Anna + Aubrey oversight ≈ $250–350K internal allocation. External legal $350–500K: estate paper $75–150K each, credit docs $50–100K per facility, SPV formation $25–40K each. Diligence, travel, conferences $60–90K. Our estimates.

Offset, same window

$900K–1.6M

Fever SPV fees: 2% on $10–20M ≈ $200–400K/yr, 3-year cap. IP SPV fees: 2% on $20M+ ≈ $400K/yr. Accretive only if origination succeeds — which is the correct incentive design.

Headcount trigger

After proof, not before

One associate (~$150–200K/yr) only after Proof 1 or Proof 3 lands. If neither lands by month 15, the category earns a smaller Stage 2, not headcount.

CUE 12LX: snap to pyro orangeSECTION B2 · VALUE-CREATION LEVERS, RANKED

Act III · Headliner — years 2–10, the $500M bridge

Five levers. One carries the show.

1 · Multiple arbitrage — the spine

Superstruct bought 60–70% festival stakes at £1.7–4M (roughly 2–5x implied) and the assembled platform sold to KKR at €1.3B — 10.8x €120M EBITDA. The spread exists because one festival is weather, hit and founder risk, while eighty diversified festivals are an institutional asset class. That diversification re-rate is purchasable at our scale.

2 · Central sponsorship — the margin lever

LN's sponsorship division runs a 64% AOI margin: $845M AOI on $1.3B revenue. Aggregated audiences convert to brand revenue no independent can reach alone. Platform-level sponsorship across 10–15 assets adds an estimated 300–600bps of blended margin without touching operations. Estimate ours.

3 · IP-attach compounding — the multiple enhancer

Estate and format IP layered onto owned distribution converts operating EBITDA into licensing-mix EBITDA. Worth one to two turns at exit — not a standalone bridge. The IP SPV alone would need 15–20x. Not creditable.

4 · Platform fees on other people's capital

Anchor 20%, raise 80%, 2-and-20. The ManCo compounds alongside the platform. GP economics are Saltwater's kicker and do not count toward platform TEV — flagged so the arithmetic stays honest.

5 · Fever distribution — priced at zero

Anything incubated scales through Fever (Moment Factory: $27M to $150M). Gate-passing ecosystem fit. Thesis is not synergy: upside, never underwriting.

CUE 13LX: orange, low hazeSECTION B2 · LEVERAGE REALISM · FRAGMENTATION FOR ROLL-UPS

How much debt the music can carry

Show-level credit

Self-liquidating against pre-sales and guarantees. That's turnover, not balance-sheet leverage. Our core instrument lives here.

Platform debt · 2.0–2.5x max

Festival and promoter cash flows are seasonal and weather-exposed. Underwrite 2.0–2.5x EBITDA at the Holdco, and only after eight-plus assets diversify the seasonality. Anything more aggressive re-creates Cirque 2020: marquee brand, fragile fixed costs, bankruptcy.

Fragmentation check

Superstruct owns 80+ festivals and still ranks second to LN, with hundreds of independents left across Europe and Australia. The US independent layer and LatAm are essentially unconsolidated at our check size. Supply is not the constraint. Seller willingness and our diligence bandwidth are.

CUE 14LX: full rig · PYRO STANDBYSECTION B2 · THE ARITHMETIC BRIDGE — $25M TO $500M. THE MATH MUST CLOSE.

The bridge

Six steps, every assumption on the table. Switch the scenario — the numbers, the bars and the verdict recompute. The table closes at base. It does not close without outside capital, and we say so.

STEP 1 · YRS 0–1.5Stage-1 seeds$25M deployed per Act II. Kickers + ASF option + IP SPV created. ~$30M SPV outside capital alongside. Look-through EBITDA ~$3–4M. Proofs 1–3 earned.
STEP 2 · YRS 2–4ProveConvert kickers. Exercise ASF at the fixed $8M (~2x embedded if at plan). Two or three more structured minorities. +$10–15M follow-on. Look-through $6–8M.
STEP 3 · YRS 3–4Holdco I raise$100M outside equity + ~$25M seller rollover + $60M debt at 2.0x acquired EBITDA ≈ $185M buying power. LP map: Nucleus/Stone Lane, Helix, Bahraini group, LaFont, Boehly-adjacent.
STEP 4 · YRS 4–8ConcentrateAcquire 10–14 festival and promoter assets at a blended 4.5x entry ≈ $160M consideration → $35M acquired EBITDA. Entry per Superstruct bolt-on comps, blended up from 2–5x for competition drift.
STEP 5 · YRS 5–9Organic + sponsorshipLive-music CAGR 8.8% (CMI) haircut to 6% ≈ +$12M over five years. Central sponsorship layer +$5M, our version far cruder than LN's 64%-margin machine. Net of attrition: $35M → $50M.
STEP 6 · YRS 8–10Exit / re-rateSale or recap to the proven buyers of exactly this asset class. KKR paid 10.8x. CVC re-bought. Exit multiple: 10x.
$500M
$50M EBITDA × 10x = $500M TEV. The table closes.

Sensitivity detail: Bear = $35M EBITDA, no organic outperformance, 7x exit → $245M. Still a fine Saltwater outcome (GP economics + ~2.5–3x on principal) but it misses the brief's bar; probability-weight it meaningfully. Base requires the Holdco raise to land at $85M or better. Bull = IP-mix re-rate to 12x on $55M. House-only = $25M compounding at 20% net for 8.5 years ≈ $118M: without the Holdco raise this category cannot reach $500M. Outside capital is not optional. It is the mechanism.

CUE 15LX: signal red wash · SAFETY BRIEFSECTION B2 · FAILURE MODES AND WHETHER THEY'RE MITIGABLE

Three ways the rig comes down

1 · Systemic demand shock

The Cirque-2020 pattern. Fixed-cost live businesses die fast in shutdowns — Cirque went bankrupt with the strongest brand in the category. Partially mitigable: credit-first structuring, the 2.0–2.5x leverage cap, mandated event-cancellation insurance. A 2020-scale event still marks the equity sleeve near zero for ~18 months.

2 · Entry-multiple compression

The thesis-killer. CVC, LN and copycat family offices bid bolt-ons from 3–5x toward 6–8x and the spine thins. Partially mitigable: stay below institutional minimum check sizes; weaponize anti-PE seller preference; source earlier via succession. Kill-switch Monitored quarterly: blended entry above ~6x for two consecutive quarters → cut Stage 2 ambition to the $250M honest cap and say so.

3 · Key-man concentration

Promoter books and festival identities are founder relationships — iKon's booker, ASF's founders, Silencio's Lynch-derived network, already stress-tested by Lynch's passing. Mostly mitigable: three-to-five-year earnouts keeping founders economically present, key-man covenants, platform booking redundancy after asset five.

Standing constraint, not a failure mode — Fever conflict discipline. The platform never competes with Fever's ticketing and demand-gen layer, or Ryan's position becomes a liability. Every Stage 2 asset carries the conflict tag at IC.

CUE 16LX: warm brass, house half upSECTION C · NAMED TARGETS, TIERED AND TAGGED · INCL. EXISTING PIPELINE

Encore · The lineup

42 names on the bill

Every act tagged: capital bucket, value-chain layer, the three-question IP test, Agnes Chu scale tier, Four C's lead with talent-dependency, and the relationship to our Fever / JGE / ASF / Grace / Ampersand / iKon / Silencio / E1 positions. IP lamps read Q1 exclude · Q2 reuse · Q3 attach — lit green passes, amber partial, red fails, hollow not applicable. Tap a row for the full read.

Tier
Cluster

CUE 17LX: brass holdSECTION C · PEOPLE TO MEET · CONFERENCES · ADVISORS TO RETAIN

Education: who teaches us this business

Ten people, in priority order

1 · James Barton, Superstruct founder — ran our exact playbook; one dinner is a quarter of diligence. 2 · Andrew McGuinness, Layered Reality CEO — the only operator who has papered an ABG estate-rights deal at our scale. 3 · Peter Shapiro, Brooklyn Bowl/Relix — de-risks JGE; knows Garcia-audience economics better than anyone alive. 4 · A Pophouse investment-team member — the €1.2B fund defines our thesis ceiling. 5 · Seth Hurwitz, I.M.P. — independent-promoter economics, and a Tier-2 target himself. 6 · Our Fever counterpart — formalize the quarterly producer-graph review. 7 · Ian Orefice, EverWonder — residency-finance underwriting standards. 8 · Danny Wimmer — US festival M&A temperature, and Tier-2. 9 · A Sonia Friedman-class West End lead producer — theater hit-risk calibration. 10 · A Superstruct/CVC deal-team member — where entry multiples are actually printing. Failure-mode-2 monitor.

Conferences & communities

ILMC London (Feb–Mar) — the independent-promoter room. Pollstar Live LA (Feb). IEBA Nashville (Oct) — routing and booking economics. Aspen Live (Dec) — senior-only, high taste bar. Skip SXSW-class generalist events: the seminar/B2B exclusion applies.

Advisors to retain

1 · Entertainment-finance counsel with estate-rights depth — JGE/Grace-class paper. 2 · An ex-LN/AEG touring CFO as fractional underwriting advisor on promoter credit, success-fee'd. 3 · An event-cancellation insurance broker relationship, established before facility #1 draws.

CUE 18LX: house lights to fullSCORING RUBRIC, 1–5 · THREE DECISIONS REQUESTED

Curtain

Scorecard, then the asks

Path to $500M3.5 — mechanism named and comped (arbitrage + $100M outside capital) but conditional on the Holdco raise; honest bear caps at $250M.
Fit for $10–25M5 — credit facilities, SPV anchors and estate carve-outs are natively $2–10M instruments. The majors can't operate at this size; we can't operate above it.
Right to win4 — Fever data, a two-deal estate record, and anti-PE cultural positioning are real and specific. Docked for zero operating capability.
Speed to proof4 — one promoter-credit cycle proves in 12–15 months; IP Q3 proof is the slow one at 18+. The expanded universe adds 2x coverage.
Team leverage3 — structuring-heavy category on shared Anna/Aubrey capacity. Earns an associate only after Proof 1 or Proof 3.
Downside shape4 — credit-first, collateralized, self-liquidating core. The $7M sleeve is genuinely bear-to-zero in a shock, and it's sized accordingly.

Weighted read: ~3.9. Strong category, contingent bridge. Fund Stage 1 fully; make Stage 2 conditional on the proofs and the multiple monitor.

ASK 1

Rule on the Fever bucket. Platform exception inside the $18M, or carve a third bucket. Decide it tonight so the allocation stands.

ASK 2

Greenlight the iKon term sheet. $4–5M anchor toward a $10–15M facility SPV. Structure is the diligence.

ASK 3

Hold the line on JGE. 12.5% direct + transfer rights + second board seat. No bridge loans. The July pass stands.

CUE 19LX: work lightsPRODUCTION CREDITS · SOURCE REGISTER · OPEN DILIGENCE FLAGS

Small print

Every claim sourced. Live Nation FY2025 — Billboard 2/20/26, Music Business Worldwide 2/19/26, LN 10-K summary via StockTitan, LN Newsroom. Broadway — Broadway League end-of-season releases 5/25, Playbill 5/28/25 and 5/27/26. Sphere — MBW 2/19/26 and 5/7/26, Sphere Q4/FY2025 release, CRE Daily/Pollstar 7/26, Las Vegas Live 2/13/26. Superstruct — NKP M&A Insights (€1.3B, ~10.8x, 6/24), MBW UK-entity accounts incl. bolt-on prices 3/5/25, Preqin (CVC, 10/24), Access AA open-letter coverage 5/25. Live-music TAM — Custom Market Insights 5/30/26, Mordor 2026; divergence flagged in-text.

Comedy — Billboard year-end via Accio, Pollstar 2026 Comedy Executive Survey 1/16/26, AEG–Outback releases 5/1/26, Billboard on the Since Entertainment spin-off 5/4/26. Just For Laughs — THR bankruptcy and asset-sale coverage 3/24–6/24 (creditors $26.5M), THR/Variety relaunch coverage 2024–25. Pophouse — MBW fund close 3/31/25, MBW/Music Week KISS deal 4/4/24, TechTimes Iron Maiden partnership 7/15/26. Layered Reality — Channel 4 PR 8/24, Crowdcube 11/24, WXO 9/25, AInvest 7/25, Prospeo estimate. Lightroom — 59.studio, lightroom.uk. DWP — Spectrum/LEO/Blabbermouth 4/25, Yahoo and MetalInsider 2025 records. UNTOLD — Romania Insider 6–7/26 and 2/23. Insomniac — Billboard/Pollstar/Forbes. MARI/TodayTix — Variety 11/3/25, Great Hill 10/20/25; Secret Cinema — THR/Variety 9/22. Internal — Saltwater Context Document, July 2026.

Open diligence flags — asserted with explicit uncertainty.

  • Another Planet founder-succession angle: our inference, not reported.
  • Zamna, Afro Nation, Don't Tell Comedy, Sofar Sounds: financials from general knowledge only; verify before outreach.
  • Sleep No More NYC closure; Superblue and Illuminarium restructurings: general knowledge; cite-check before quoting in the room.
  • Estate candidates — Miles Davis, Nina Simone, Fela Kuti, Marley: rights status, family dynamics and encumbrances (incl. possible Primary Wave positions) unconfirmed. A sourcing list, not a pipeline claim.
  • Theatrical licensing catalog ownership details: verify.
  • SAM figures and the sponsorship-margin uplift (300–600bps): our estimates, labeled as such throughout.
  • ComediHa!/JFL: the no-turnarounds house rule gets argued at IC before any term sheet.
  • Immersive headline TAMs: excluded as unusable. A defensible bottoms-up number was not attainable in one week.

House rules honored: lead with the answer · cash-flowing vs mid-stage vs venture-taste separated · value-chain position tagged and the three-question IP test run on every name · talent-dependency and middle-market positioning flagged · no agencies below Moment Factory scale · nothing below $10M SPV viability except $250K taste checks · every opportunity framed against Fever · when in doubt, if it's this hard to say yes, the answer is no.

Production notes. Lighting effects are decorative and can be switched off with the FX control, top right. Brief light-flicker moments are disabled automatically when the system asks for reduced motion. Confidential: Saltwater investment team only. Named targets stay in this room. Independent work product — not coordinated with the other three category readouts. Written and argued by the category lead; typos are his too.